AbbVie Inc. (ABBV)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 01:29PM EDT. Market open.
| Previous close | 160.40 |
| Open | 160.71 |
| Bid | 160.87 x 800 |
| Ask | 160.90 x 1000 |
| Day's range | 160.35 - 161.14 |
| 52-week range | 130.96 - 182.89 |
| Volume | |
| Avg. volume | 5,693,053 |
| Market cap | 284.04B |
| Beta (5Y monthly) | 0.59 |
| PE ratio (TTM) | 48.01 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 6.20 (3.87%) |
| Ex-dividend date | 12 Apr 2024 |
| 1y target est | N/A |
- Zacks
Ironwood (IRWD) Q1 Earnings & Revenues Fall Shy of Estimates
Ironwood (IRWD) incurs loss in the first quarter of 2024. Revenues decline year over year and miss estimates. The company lowers revenue guidance for 2024. Stock falls.
- Barrons.com
Teva Stock Powers Ahead as Schizophrenia News Offsets Mixed Earnings
Shares of Teva Pharmaceutical Industries were climbing yet again on Wednesday, after the company announced positive results in a trial of a schizophrenia medicine. Its quarterly results, also disclosed early Wednesday, were mixed. Revenue was $3.8 billion for the quarter, slightly better than the FactSet consensus estimate of $3.7 billion, while non-GAAP diluted earnings were 48 cents a share.
© 2024 Yahoo. All rights reserved.